SG10201507120TA - Treatment of diseases - Google Patents
Treatment of diseasesInfo
- Publication number
- SG10201507120TA SG10201507120TA SG10201507120TA SG10201507120TA SG10201507120TA SG 10201507120T A SG10201507120T A SG 10201507120TA SG 10201507120T A SG10201507120T A SG 10201507120TA SG 10201507120T A SG10201507120T A SG 10201507120TA SG 10201507120T A SG10201507120T A SG 10201507120TA
- Authority
- SG
- Singapore
- Prior art keywords
- diseases
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38040410P | 2010-09-07 | 2010-09-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201507120TA true SG10201507120TA (en) | 2015-10-29 |
Family
ID=45771136
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2013015680A SG187986A1 (en) | 2010-09-07 | 2011-09-07 | Treatment of diseases |
| SG10201507120TA SG10201507120TA (en) | 2010-09-07 | 2011-09-07 | Treatment of diseases |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2013015680A SG187986A1 (en) | 2010-09-07 | 2011-09-07 | Treatment of diseases |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US20120058934A1 (en) |
| EP (1) | EP2613795B1 (en) |
| JP (2) | JP5941047B2 (en) |
| KR (1) | KR101822951B1 (en) |
| CN (1) | CN103200952B (en) |
| AU (1) | AU2011299353B2 (en) |
| BR (1) | BR112013005432A8 (en) |
| CA (1) | CA2810834C (en) |
| CO (1) | CO6710904A2 (en) |
| EA (1) | EA023932B1 (en) |
| ES (1) | ES2611878T3 (en) |
| HK (1) | HK1182617A1 (en) |
| IL (1) | IL224931A (en) |
| MX (1) | MX343160B (en) |
| NZ (1) | NZ607600A (en) |
| SG (2) | SG187986A1 (en) |
| WO (1) | WO2012033789A2 (en) |
| ZA (1) | ZA201301601B (en) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2774959C (en) | 2000-08-04 | 2016-05-31 | Dmi Biosciences, Inc. | Method of using diketopiperazines and composition containing them |
| PT2537524T (en) * | 2003-05-15 | 2016-09-05 | Ampio Pharmaceuticals Inc | Treatment of t-cell mediated diseases |
| WO2009146320A1 (en) | 2008-05-27 | 2009-12-03 | Dmi Life Sciences, Inc. | Therapeutic methods and compounds |
| CN103200952B (en) * | 2010-09-07 | 2016-04-06 | 安皮奥制药股份有限公司 | The treatment of disease |
| EP2613786A4 (en) | 2010-09-07 | 2013-10-23 | Dmi Acquisition Corp | Treatment of diseases |
| MY167804A (en) | 2011-10-10 | 2018-09-26 | Ampio Pharmaceuticals Inc | Treatment of degenerative joint disease |
| EP2765968A4 (en) | 2011-10-10 | 2015-01-21 | Ampio Pharmaceuticals Inc | Implantable medical devices with increased immune tolerance, and methods for making and implanting |
| JP6231484B2 (en) | 2011-10-28 | 2017-11-15 | アンピオ ファーマシューティカルズ，インコーポレイテッド | Rhinitis treatment |
| CA2906864A1 (en) | 2013-03-15 | 2014-09-18 | Ampio Pharmaceuticals, Inc. | Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same |
| ES2781558T3 (en) | 2013-06-10 | 2020-09-03 | Suntory Holdings Ltd | Plant extract containing diketopiperazine and method of its production |
| CN103913853A (en) * | 2013-07-05 | 2014-07-09 | 马准吾 | Contact lens having cooling coating layer |
| JP6723222B2 (en) | 2014-08-18 | 2020-07-15 | アンピオ ファーマシューティカルズ，インコーポレイテッド | Treatment of joint pathology |
| EP3310375A4 (en) | 2015-06-22 | 2019-02-20 | Ampio Pharmaceuticals, Inc. | Use of low molecular weight fractions of human serum albumin in treating diseases |
| WO2017018404A1 (en) | 2015-07-27 | 2017-02-02 | サントリーホールディングス株式会社 | Composition containing cyclic dipeptide and sweetening agent |
| KR102396603B1 (en) | 2015-09-16 | 2022-05-11 | 원광대학교산학협력단 | Composition for improving liver function comprising citrulline as an active ingredient |
| CN105879005A (en) * | 2016-02-01 | 2016-08-24 | 四川好医生攀西药业有限责任公司 | Pharmaceutical composition for treating ulcerative colitis as well as preparation method and application of pharmaceutical composition |
| CN109563150A (en) * | 2016-07-26 | 2019-04-02 | 安皮奥制药股份有限公司 | By the treatment for the disease that vascular hyperpermeability mediates |
| US11026625B2 (en) | 2017-08-08 | 2021-06-08 | Fresenius Medical Care Holdings, Inc. | Systems and methods for treating and estimating progression of chronic kidney disease |
| JP6741280B2 (en) * | 2018-03-29 | 2020-08-19 | 株式会社ウォーターエージェンシー | Composition used for ACE inhibition, suppression of blood pressure increase, or blood pressure reduction, and method for producing the same |
| WO2021195265A1 (en) | 2020-03-24 | 2021-09-30 | Ampio Pharmaceuticals, Inc. | Methods for treating diseases associated with respiratory viruses |
| CN113754598B (en) * | 2021-09-29 | 2023-06-06 | 四川大学 | Diamine and polyimide containing cyclic peptide structure and preparation method thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000327575A (en) * | 1999-05-26 | 2000-11-28 | Teika Seiyaku Kk | Remedy for inflammatiory disease containing diketopiperazine derivative and new diketopiperazine derivative |
| CA2774959C (en) * | 2000-08-04 | 2016-05-31 | Dmi Biosciences, Inc. | Method of using diketopiperazines and composition containing them |
| PT2537524T (en) * | 2003-05-15 | 2016-09-05 | Ampio Pharmaceuticals Inc | Treatment of t-cell mediated diseases |
| CN101279094A (en) * | 2003-05-15 | 2008-10-08 | Dmi生物科学公司 | Treatment of T-cell mediated diseases |
| EP2203051A4 (en) * | 2007-09-25 | 2011-09-07 | Abbott Lab | Octahydropentalene compounds as chemokine receptor antagonists |
| WO2009146320A1 (en) * | 2008-05-27 | 2009-12-03 | Dmi Life Sciences, Inc. | Therapeutic methods and compounds |
| CN103200952B (en) * | 2010-09-07 | 2016-04-06 | 安皮奥制药股份有限公司 | The treatment of disease |
| EP2613786A4 (en) * | 2010-09-07 | 2013-10-23 | Dmi Acquisition Corp | Treatment of diseases |
-
2011
- 2011-09-07 CN CN201180053553.8A patent/CN103200952B/en active Active
- 2011-09-07 NZ NZ607600A patent/NZ607600A/en not_active IP Right Cessation
- 2011-09-07 CA CA2810834A patent/CA2810834C/en not_active Expired - Fee Related
- 2011-09-07 ES ES11824038.1T patent/ES2611878T3/en active Active
- 2011-09-07 SG SG2013015680A patent/SG187986A1/en unknown
- 2011-09-07 EA EA201390347A patent/EA023932B1/en not_active IP Right Cessation
- 2011-09-07 MX MX2013002566A patent/MX343160B/en active IP Right Grant
- 2011-09-07 KR KR1020137008193A patent/KR101822951B1/en active IP Right Grant
- 2011-09-07 AU AU2011299353A patent/AU2011299353B2/en not_active Ceased
- 2011-09-07 WO PCT/US2011/050612 patent/WO2012033789A2/en active Application Filing
- 2011-09-07 US US13/227,098 patent/US20120058934A1/en not_active Abandoned
- 2011-09-07 EP EP11824038.1A patent/EP2613795B1/en active Active
- 2011-09-07 JP JP2013528256A patent/JP5941047B2/en not_active Expired - Fee Related
- 2011-09-07 BR BR112013005432A patent/BR112013005432A8/en not_active IP Right Cessation
- 2011-09-07 SG SG10201507120TA patent/SG10201507120TA/en unknown
-
2013
- 2013-02-26 IL IL224931A patent/IL224931A/en active IP Right Grant
- 2013-03-01 ZA ZA2013/01601A patent/ZA201301601B/en unknown
- 2013-04-05 CO CO13089531A patent/CO6710904A2/en unknown
- 2013-08-23 HK HK13109875.6A patent/HK1182617A1/en not_active IP Right Cessation
-
2016
- 2016-05-19 JP JP2016100487A patent/JP2016145261A/en active Pending
-
2019
- 2019-09-25 US US16/582,953 patent/US20200016152A1/en not_active Abandoned
-
2020
- 2020-11-05 US US17/090,673 patent/US20210052578A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MX2013002566A (en) | 2013-06-18 |
| EP2613795A4 (en) | 2013-10-30 |
| IL224931A (en) | 2017-05-29 |
| EA201390347A1 (en) | 2013-07-30 |
| SG187986A1 (en) | 2013-03-28 |
| CN103200952B (en) | 2016-04-06 |
| JP2016145261A (en) | 2016-08-12 |
| NZ607600A (en) | 2015-05-29 |
| US20200016152A1 (en) | 2020-01-16 |
| BR112013005432A8 (en) | 2017-12-05 |
| WO2012033789A3 (en) | 2012-05-31 |
| EP2613795A2 (en) | 2013-07-17 |
| WO2012033789A2 (en) | 2012-03-15 |
| EA023932B1 (en) | 2016-07-29 |
| EP2613795B1 (en) | 2016-10-26 |
| CA2810834A1 (en) | 2012-03-15 |
| MX343160B (en) | 2016-10-26 |
| AU2011299353A1 (en) | 2013-03-14 |
| KR101822951B1 (en) | 2018-01-29 |
| JP2013537194A (en) | 2013-09-30 |
| US20120058934A1 (en) | 2012-03-08 |
| HK1182617A1 (en) | 2013-12-06 |
| JP5941047B2 (en) | 2016-06-29 |
| US20210052578A1 (en) | 2021-02-25 |
| BR112013005432A2 (en) | 2016-06-07 |
| CN103200952A (en) | 2013-07-10 |
| ES2611878T3 (en) | 2017-05-11 |
| KR20140003399A (en) | 2014-01-09 |
| ZA201301601B (en) | 2018-12-19 |
| CO6710904A2 (en) | 2013-07-15 |
| CA2810834C (en) | 2017-03-21 |
| AU2011299353B2 (en) | 2016-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201301601B (en) | Treatment of diseases | |
| EP2613786A4 (en) | Treatment of diseases | |
| ZA201304280B (en) | Treatment of jak2-mediated conditions | |
| EP2621499A4 (en) | Methods for the treatment of allergic diseases | |
| IL220876A0 (en) | Treatment of cardiac conditions | |
| EP2723384A4 (en) | Treatment of proteinopathies | |
| EP2605827A4 (en) | Non-invasive treatment of bronchial constriction | |
| HK1217763A1 (en) | Methods of treating diseases | |
| SG10201508495VA (en) | Combination treatment of cancer | |
| ZA201300218B (en) | Treatment of blood cancer | |
| HK1199261A1 (en) | Methods for treatment of diseases | |
| IL256026A (en) | Methods of treatment | |
| EP2623494A4 (en) | Agent for treatment of eye diseases | |
| EP2640220A4 (en) | Treatment of nail disease | |
| IL225896A0 (en) | Treatment of mecp2-associated disorders | |
| ZA201208389B (en) | Treatment of proliferative diseases | |
| EP2608804A4 (en) | Treatment of renal diseases | |
| EP2544686A4 (en) | Combination methods for treatment of disease | |
| EP2522360A4 (en) | Vaccine for treatment of tautopathy | |
| EP2556161A4 (en) | Methods for the treatment of autoimmune diseases | |
| IL222690A0 (en) | Treatment of autoimmune diseases | |
| GB201107467D0 (en) | Novel treatment of pain | |
| EP2625180A4 (en) | Porphyrin treatment of neurodegenerative diseases | |
| GB201009194D0 (en) | Treatment of pain | |
| ZA201008686B (en) | Treatment of animals |